Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

KCC1 Inhibitors

KCC1 Inhibitors, though not directly targeting the Potassium-Chloride Cotransporter 1 (KCC1), encompasses a variety of compounds primarily influencing ion transport and homeostasis in cellular environments. This class includes diverse groups such as loop diuretics, thiazide diuretics, angiotensin II receptor blockers, mineralocorticoid receptor antagonists, and sodium-glucose transport inhibitors. The unifying theme across these compounds is their indirect modulation of ionic balances within cells, which can potentially impact the function of KCC1. For instance, loop diuretics like Furosemide and Torasemide target the NKCC cotransporters, leading to altered chloride transport dynamics, closely associated with KCC1's role in maintaining chloride and potassium equilibrium. Thiazide diuretics such as Hydrochlorothiazide affect sodium chloride transport, which can indirectly influence the cellular conditions governed by KCC1. The variations in the chemical structures and properties within this class are substantial, given the diverse mechanisms through which these compounds interact with ion transport processes.

Compounds like Valsartan, a member of the angiotensin II receptor blocker family, and Eplerenone or Spironolactone, which are mineralocorticoid receptor antagonists, contribute to the modulation of ion transport and fluid balance within cells, impacting the ionic landscape where KCC1 operates. On the other hand, sodium-glucose transport inhibitors such as Dapagliflozin, Canagliflozin, and Empagliflozin, work by inhibiting SGLT proteins, thereby affecting the sodium balance, which in turn can influence the activity of KCC1. The diverse chemical structures in this class, ranging from complex ring systems to linear molecules, reflect the variety of molecular interactions they engage in to influence ion transport. The specificity and selectivity of these compounds for their primary targets are a hallmark of their chemical nature, yet their indirect impact on KCC1 function is a consequence of the interconnected nature of cellular ion transport mechanisms. This chemical class exemplifies how alterations in one aspect of cellular homeostasis can cascade to affect related transport systems, demonstrating the intricate balance maintained within cellular environments.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Furosemide

54-31-9sc-203961
50 mg
$40.00
(1)

A loop diuretic inhibiting NKCC (sodium-potassium-chloride cotransporter), potentially affecting KCC1 indirectly by altering chloride transport.

Bumetanide (Ro 10-6338)

28395-03-1sc-200727
sc-200727A
1 g
5 g
$107.00
$224.00
9
(1)

Inhibits NKCC1 and NKCC2, potentially influencing KCC1 activity through changes in cellular ion balance.

Hydrochlorothiazide

58-93-5sc-207738
sc-207738A
sc-207738B
sc-207738C
sc-207738D
5 g
25 g
50 g
100 g
250 g
$54.00
$235.00
$326.00
$551.00
$969.00
(0)

A thiazide diuretic affecting sodium chloride transport, could indirectly impact KCC1 activity.

Valsartan

137862-53-4sc-220362
sc-220362A
sc-220362B
10 mg
100 mg
1 g
$39.00
$90.00
$120.00
4
(1)

An angiotensin II receptor blocker, influencing ion transport and possibly impacting KCC1 indirectly.

Amiloride

2609-46-3sc-337527
1 g
$290.00
7
(1)

Inhibits epithelial sodium channels, potentially altering the ionic environment relevant to KCC1 function.

Spironolactone

52-01-7sc-204294
50 mg
$107.00
3
(1)

A potassium-sparing diuretic, which may affect KCC1 by altering potassium balance in cells.

Eplerenone

107724-20-9sc-203943
sc-203943A
10 mg
50 mg
$108.00
$612.00
4
(1)

Selectively inhibits the mineralocorticoid receptor, potentially impacting KCC1 indirectly via ion homeostasis.

Triamterene

396-01-0sc-213103A
sc-213103
1 g
5 g
$22.00
$53.00
(0)

A potassium-sparing diuretic, could influence KCC1 activity by altering intracellular potassium levels.

Dapagliflozin

461432-26-8sc-364481
sc-364481A
sc-364481B
5 mg
50 mg
1 g
$115.00
$420.00
$1030.00
6
(1)

Inhibits sodium-glucose transport proteins, potentially affecting KCC1 by altering cellular ionic conditions.

Canagliflozin

842133-18-0sc-364454
sc-364454A
5 mg
50 mg
$306.00
$408.00
2
(0)

Another inhibitor of sodium-glucose transporters, may impact KCC1 indirectly.